跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 19,747 条关于
“thyroid hormone receptor β”
全部
19,747
临床试验
11,862
药物
1,787
机构
59
资讯
6,039
2年前
Resmetirom and GLP-1 Agonists Show Promise in Treating MASH
去年
Evolving Landscape of MASLD: New Insights and Therapeutic Approaches
去年
Real-World Data Show Resmetirom Mirrors Clinical Trial Success in MASH Patients
去年
FDA Approves Rezdiffra (resmetirom) for NASH with Liver Fibrosis
去年
FDA Approvals in 2024: NASH Treatment, DMD Therapy, Novel Schizophrenia Drug, and Breast Cancer Advancement
3个月前
Rezdiffra Demonstrates Cardiovascular and Liver Risk Reduction in MASH Patients
去年
Rezdiffra Demonstrates Improved Quality of Life in NASH Patients with Fibrosis
2年前
FDA Approves Resmetirom (REZDIFFRA™) as First Treatment for NASH
去年
Madrigal's Resmetirom Shows Promise in NASH Treatment Where Others Have Failed
7年前
FDA Approves Resmetirom (Rezdiffra) for Treating MASH and Associated Fibrosis
第 1 页，共 604 页
上一页
下一页
